Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 3,7613,780 of 20,252 grants

Active NON-SBIR/STTR RPGS
Southwest EDRN Clinical Validation Center for Head and Neck Cancer
NATIONAL CANCER INSTITUTE Arizona State University-Tempe Campus United States 2023 – 2028

Project Summary/Abstract The goal of the EDRN Southwest Clinical Validation Center for Head and Neck Cancer is to improve oropharyngeal cancerscreening through the rigorous validat...

$7.48M
USD
Active OTHER RESEARCH-RELATED
Preclinical Validation of Personalized Molecular Assays for Measurable Residual Disease Monitoring in Pediatric AML
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT My long-term career goal is to improve outcomes for pediatric patients with acute myeloid leukemia (AML), in part through development of improved modalitie...

$2.28M
USD
Active NON-SBIR/STTR RPGS
Matching genotypes with personalized therapies: Development of a decision support infrastructure to augment the value of precision medicine
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2023 – 2026

Project Summary Despite the progress made in precision oncology, clinicians typically face a vast volume and variety of next- generation sequencing and molecular data that is frequ...

$4.08M
USD
Active TRAINING, INDIVIDUAL
Hypoxic regulation of macrophage migration and function via fibroblast reprogramming in pancreatic cancer
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2023 – 2027

PROJECT SUMMARY Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer-related deaths in the United States despite representing only 2% of all cancer cases. P...

$408.1K
USD
Active NON-SBIR/STTR RPGS
A Type I Hybrid Effectiveness-Implementation Trial to Evaluate a Navigation-Based Multilevel Intervention to Decrease Delays Starting Adjuvant Therapy Among Patients with Head and Neck Cancer
NATIONAL CANCER INSTITUTE Medical University of South Carolina United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT This R01 proposal aims to test the effectiveness, mechanism, and implementation of a navigation-based multilevel intervention to improve the delivery of ti...

$7.52M
USD
Active NON-SBIR/STTR RPGS
Autoantibodies to tumor-derived neoepitopes as biomarkers and immunoPET agents for the early detection of small cell lung cancer
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2023 – 2028

Project Summary/Abstract Small-cell lung cancer (SCLC) kills over 30,000 Americans every year and has a dismal 5-year overall survival rate of less than 7%. However, SCLC outcomes...

$5.82M
USD
Active NON-SBIR/STTR RPGS
Dissecting the tumor-intrinsic and -extrinsic roles of TBK1 in tumor immunity
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2023 – 2028

Project Summary Immune checkpoint blockade (ICB) targeting the PD-1/PD-L1 pathway has induced dramatic and durable clinical responses in melanoma and other cancers. Despite the suc...

$6.31M
USD
Active NON-SBIR/STTR RPGS
Metabolic flux analysis and PDX models to understand therapeutic vulnerabilities following inhibition of Ref-1 redox signaling in pancreatic cancer
NATIONAL CANCER INSTITUTE Indiana University Indianapolis United States 2023 – 2028

ABSTRACT Pancreatic ductal adenocarcinoma (PDAC) is particularly resistant to therapy and typically presents as metastatic disease. Characterized by hypoxia, dense stroma, and meta...

$4.66M
USD
Active NON-SBIR/STTR RPGS
Clinical, molecular, and immune characterization of naturally occurring osteosarcoma in dogs
NATIONAL CANCER INSTITUTE University of California At Davis United States 2023 – 2028

PROJECT SUMMARY Naturally occurring osteosarcoma in dogs has been proposed as a promising translational platform to serve as an intermediary between mouse studies and human clinica...

$5.85M
USD
Active NON-SBIR/STTR RPGS
Enhancing TET activity for the treatment of hematological malignancy
NATIONAL CANCER INSTITUTE University of Miami School of Medicine United States 2023 – 2028

PROJECT SUMMARY Advanced age in the majority of acute myeloid leukemia (AML) patients limits the use of aggressive chemotherapy leading to poor overall survival. Alternative treatm...

$3.51M
USD
Active NON-SBIR/STTR RPGS
Investigating the roles of oncogenic extrachromosomal circular DNAs in cancer
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2023 – 2028

ABSTRACT Increased oncogene expression mediated by focal amplifications is a common mechanism for oncogene activation in human cancers. Two major mechanisms leading to oncogene amp...

$5.67M
USD
Active NON-SBIR/STTR RPGS
Validation of an aqueous humor liquid biopsy for molecular prognostication and monitoring of children with retinoblastoma.
NATIONAL CANCER INSTITUTE Children'S Hospital of Los Angeles United States 2023 – 2028

Project Summary There is a significant body of research into the genetic, genomic and epigenomic alterations of retinoblastoma (RB), a primary eye cancer that forms in the developi...

$5.82M
USD
Completed NON-SBIR/STTR RPGS
Nuclear envelope and predisposition to hepatic neoplasia
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2023 – 2024

PROJECT SUMMARY Chronic liver diseases such as nonalcoholic steatohepatitis significantly increase the risk of cirrhosis and hepatocellular carcinoma (HCC). However, the underlying...

$1.17M
USD
Completed OTHER RESEARCH-RELATED
The Role of Platelets in Establishing the Lung Pre-Metastatic Niche in Breast Cancer
NATIONAL CANCER INSTITUTE Brigham and Women'S Hospital United States 2023 – 2025

PROJECT SUMMARY Tumor metastasis remains responsible for >65% of cancer-associated mortality and nearly all breast cancer deaths. Given the difficulties in treating metastatic d...

$1.78M
USD
Active OTHER RESEARCH-RELATED
Leveraging Health Systems to Increase Implementation of Evidence-based Surgical Cancer Care
NATIONAL CANCER INSTITUTE University of Alabama At Birmingham United States 2023 – 2028

PROJECT SUMMARY Hospitals are increasingly consolidating into health systems with shared ownership and management. Care in a health system has potential benefits for surgical cance...

$1.97M
USD
Completed NON-SBIR/STTR RPGS
Dissecting Neuro-Immune Interactions in Cancer
NATIONAL CANCER INSTITUTE University of Basel Switzerland 2023 – 2025

PROJECT SUMMARY/ABSTRACT: Cancer is highly adept at exploiting normal physiological functions to support its growth. One important component of tissue physiology is neurons which w...

$1.43M
USD
Completed NON-SBIR/STTR RPGS
Inducing Tumor Neoantigens Through RNA Editing for Cancer Immunotherapy
NATIONAL CANCER INSTITUTE University of Chicago United States 2023 – 2025

PROJECT SUMMARY/ABSTRACT Immune checkpoint inhibitors (ICIs) have revolutionized cancer immunotherapy but remain effective in only a subset of patients and tumor types. The success...

$2.47M
USD
Active NON-SBIR/STTR RPGS
Synthetic introns for selective targeting of RNA splicing factor-mutant leukemia
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2023 – 2028

SUMMARY Many cancers carry recurrent, change-of-function mutations affecting RNA splicing factors, resulting in sequence-specific changes in RNA splicing that promote disease initi...

$7.49M
USD
Completed NON-SBIR/STTR RPGS
Managing metabolic disruption in pancreatic cancer to prevent weight loss and improve quality of life
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2023 – 2025

PROJECT SUMMARY Pancreatic ductal adenocarcinoma (PDAC) is the fourth-leading cause of cancer death in the United States, with 60 000 cases diagnosed annually and five-year surviva...

$2.48M
USD
Active OTHER RESEARCH-RELATED
Microbial Dysbiosis in Pancreatic Cancer Initiation and Progression
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2023 – 2028

Project Summary Pancreatic adenocarcinoma is a devastating disease with a five-year survival of only 10%. The rise of immunotherapy has led to breakthrough treatments in many cance...

$2.81M
USD